Home About Us Products Clinical Trials Media Career Contact Us
 
CLINICAL TRIALS > EVALUATION IN LONG LESIONS
Supralimus®

EVALUATION IN LONG LESIONS (39 mm) 

Study Design
   Principal Investigator: Dr. Atul Abhyankar
   Title: Evaluation of safety, efficacy & procedural outcomes of extra long Sirolimus coated stent with Novel Polymeric
  technology for long de novo coronary lesion.
   Design: Retrospective, Multicenter, Open label registry
   No. of Centers: 3 (India)
   No. of Patients: 50
   Status: Completed
* Published in Catheterization Cardiovascular Interventions 30 November – 2 December 2006
RISK FACTORS (%)  
Diabetes 34%  
Hypertension 28%  
Hyperlipidaemia 18%  
Previous MI 22%  
Angiographic Follow up
  Pre PTCA Post PTCA 6 Months F-up  
RVD 2.92 + 0.59 2.89 + 0.56 2.94 + 0.60  
Lesion MLD 0.46 + 0.18 2.91 + 0.59 2.84 + 0.62  
Loss of MLD     0.16 + 0.14  
Binary Restenosis     2%  
Loss of MLD
Site Luminal loss(mm)  
2 mm pre stent 0.09 + 0.06  
Proximal 0.12 + 0.10  
Mid 0.18 + 0.16  
Distal 0.09 + 0.08  
2 mm post stent 0.06 + 0.08  

MACE at 30 DAYS FOLLOW-UP: 0%

 

MACE at 3 MONTH FOLLOW-UP: 0%

 
   

MACE at 6 Month Follow-up

 
Events N  
Death 0    
MI 0    
TLR 1    
TVR 1    
SAT/ DT 0    
MACE 1    
 
 
Sahajanand Medical Technologies Pvt. Ltd. - "Sahajanand Estate", Wakhariawadi, Nr. Dabholi Char Rasta, Ved Road, Surat - 395004 (Guj.), India
Tel: +91-261-2521251-58 Fax: +91-261-2520252 © Copyright 2008. All rights reserved. Last Update: 2008/05/14